Table 2.
The serum oxytocin (OXY), brain-derived neurotrophic factor (BDNF), and tropomyosin-related kinase B receptor (TrkB) levels in the adolescent anorexic inpatients in the acute stage of the disease (AN-T1) as well as after partial weight recovery (AN-T2), and in the control group (CG).
OXY (pg/ml) | BDNF (ng/ml) | TrkB (ng/ml) | |
---|---|---|---|
AN-T1 | 127.46 ± 58.68 | 28.66 ± 6.70 | 1.67 ± 0.54 |
AN-T2 | 127.90 ± 106.13 | 30.75 ± 8.34 | 1.93 ± 0.53 |
CG | 70.72 ± 39.75 | 34.66 ± 7.40 | 1.74 ± 0.53 |
AN-T1 vs. CG | |||
df | 58 | 67 | 67 |
p | 0.000 | 0.001 | 0.584 |
t | 4.385 | -3.521 | -5.551 |
md (95% cl) | 56.740 (30.760–82.719) | -5.998 (-9.398–(-2.597) | -0.071 (-0.330–0.187) |
power | 0.99 | 0.98 | 0.09 |
AN-T1 vs. AN-T2 | |||
df | 29 | 38 | 38 |
p | 0.973 | 0.057 | 0.000 |
t | -0.034 | -1.965 | -4.102 |
md (95% cl) | -0.447 (-27.274–26.379) | -2.087 (-4.239–0.063) | -0.260 (-0.388–(-0.131) |
power | 0.05 | 0.30 | 0.72 |
AN-T2 vs. CG | |||
df | 58 | 67 | 67 |
p | 0.008 | 0.047 | 0.147 |
t | 2.764 | -2.025 | 1.468 |
md (95% cl) | 57.187 (15.769–98.604) | -3.910 (-7.764–(-0.056) | 0.188 (-0.067–0.445) |
power | 0.83 | 0.55 | 0.31 |